(MENAFN- Gulf Times) The World Innovation Summit for Health (WISH), a global initiative of Qatar Foundation, is supporting the Arab Diabetes Medical Congress, taking place in Doha today and tomorrow.
Held at Oryx Rotana, the Arab Diabetes Medical Congress is organised by Maarefah Management in partnership with Qatar Diabetes Association under the patronage of the Supreme Council of Health.
As part of the congress, WISH will spread awareness about its recently published report "Rising to The Challenge: Preventing and Managing Type 2 Diabetes", sharing recommendations and extensive research undertaken in the lead-up to the recent WISH summit.
WISH's participation underscores its commitment to inspire and diffuse healthcare innovation and best practice through a global network of high-level policymakers, academics and industry leaders. It remains closely aligned to the vision and mission of Qatar Foundation to unlock human potential and underscore Qatar's pioneering role as an emerging centre for healthcare innovation.
Egbert Schillings, chief executive officer, WISH, said: "The Arab Diabetes Medical Congress is a conduit for thought leaders, policymakers and healthcare experts to align and work together on addressing this huge health threat. Type 2 diabetes is fast becoming a regional epidemic and we cannot underestimate the impact this disease will have on society, workforces and future generations."
The congress will bring together experts from around the word to discuss preventative measures and improved treatment for tackling the increasing occurrence of diabetes in the Middle East.
Diabetes is a disease that is prevalent in the Gulf region, with the incidence as high as 12-18% across the Middle East. According to the International Diabetes Federation (IDF), by 2035, the countries with the highest growth in diabetes prevalence will be the UAE, Oman and Qatar. Rates in the Middle East and North Africa as a whole will increase by 96.2% by 2035. Meanwhile, treating the complications associated with diabetes can account for up to 11% of healthcare spending.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.